Clinical trial
Application of Ectoin Lozenges (EHT02) in Patients With Oropharyngeal Allergic Symptoms
NCT03975257 is registered in ClinicalTrials.gov with Bitop AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of Ectoin Lozenges (EHT02) in Patients With Oropharyngeal Allergic Symptoms
- Lead sponsor
- Bitop AG
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 4, 2019
- Completion date
- September 12, 2019
- Enrollment
- 90 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
allergy